ArticleFrontiers in public health2026
Metal accumulation in paired colon cancer and adjacent tissues and its relationship with genotoxic and epigenetic biomarkers.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Environmental exposure to toxic and trace metals has been implicated in colorectal carcinogenesis through oxidative DNA damage and epigenetic dysregulation. However, human evidence linking tissue-level metal accumulation with epigenetic and genotoxic biomarkers remains limited, particularly in studies using paired tumor and adjacent non-cancerous colon tissues. Objectives: This study aimed to (i) characterize concentrations of selected toxic and trace metals in paired cancerous and non-cancerous colon tissues, (ii) examine associations between tissue metal concentrations and global DNA methylation in colon tissue, and (iii) evaluate relationships between tissue metal burden and circulating biomarkers of oxidative DNA damage and global DNA methylation in peripheral blood. Methods: Fifty adult patients with newly diagnosed primary colon cancer undergoing surgical resection were included. Concentrations of lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As), chromium (Cr), and titanium (Ti) were measured in paired colon tissue samples using ICP-MS. Global DNA methylation was assessed in colon tissue and peripheral blood using ELISA-based quantification of 5-methylcytosine, while oxidative DNA damage in peripheral blood lymphocytes was measured using the comet assay (tail moment). Paired comparisons were conducted using the Wilcoxon signed-rank test. Multivariable linear regression models adjusted for age, sex, body mass index, education, and tumor location were used to evaluate associations between metals, a composite Metal Burden Index, DNA methylation, and oxidative DNA damage. Results: Cadmium concentrations were significantly lower in cancerous compared with non-cancerous colon tissue (median 0.011 vs. 0.019 μg/g wet weight; Conclusions: In this cross-sectional study, metal accumulation in colon tissue was not consistently associated with global DNA methylation in tissue or blood. The limited concordance between tissue-based metal concentrations and circulating epigenetic or genotoxic biomarkers highlights the complexity of exposure-biomarker relationships in established colon cancer and suggests that blood-based markers may inadequately reflect localized tissue-level processes, with implications for environmental exposure assessment and public health biomonitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.